PillRx only · Tablet · Oral
Amlodipine And Valsartan
Amlodipine + Valsartan
5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US24 NDCs
5 active makers
5 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 16 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.387
Latest avg · Jul 22, 2026
-28%
Since Dec 17, 2025
5
Active US suppliers
50%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
15K
Rx · 2026 Q1
736K
Units dispensed
+111%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it5 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Macleods Pharmaceuticals Limited | unknown | 12 | SUPPLYING |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | unknown | 8 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 8 | SUPPLYING |
| Strides Pharma Science Limited | unknown | 8 | SUPPLYING |
| Golden State Medical Supply, Inc. | unknown | 4 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.